Clinical studies

Most of our young patients with cancer and severe blood diseases can participate in clinical trials of the GPOH (Pediatric Oncology and Hematology Society) and thus, gain access to state-of-the-art diagnostics and therapies. An overview of ongoing pediatric oncology studies, including numerous therapy optimization studies, is provided by the GPOH study portal.

If the children and adolescents suffer from relapse despite first-line therapy and intensive pre-treatment, their chances of recovery are often not good - especially in the case of solid tumors or brain tumors. Thanks to far-reaching developments in molecular genetic analysis and a large number of new so-called targeted drugs and immuno therapeutic approaches, we now have reason to hope that we will be able to help these children better in the future. As part of the KiTZ translational program, the KiTZ Clinical Trial Unit develops experimental phase I/II clinical trials to test new therapeutic approaches. With this individualized approach, the study unit takes on a pioneering role in Germany.

For additional information see: